A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations

PHASE2CompletedINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Parkinson Disease
Interventions
DRUG

1. Tesofensine (NS 2330)

Trial Locations (50)

3100

Landesklinikum St. Pölten, Sankt Pölten

4020

Landesnervenklinik Wagner Jauregg Linz, Linz

4021

AKH der Stadt Linz, Linz

6020

Univ.-Klinik für Neurologie, Innsbruck

8020

Krankenhaus d. Barmherzigen Brüder Graz-Eggenberg, Graz

8036

Univ.-Klinik für Neurologie, Graz

10117

Universitätsklinikum der Humboldt-Universität, Berlin

10178

Boehringer Ingelheim Investigational Site, Berlin

12163

Boehringer Ingelheim Investigational Site, Berlin

12167

Boehringer Ingelheim Investigational Site, Berlin

13385

Hôpital de la Timone, Marseille

13507

Boehringer Ingelheim Investigational Site, Berlin

13616

Hôpital du Pays d'Aix, Aix-en-Provence

15706

Hospital Clínico niversitario de Santiago de Compostela, Santiago de Compostela

18147

Universitätsklinik Rostock, Rostock

24105

Christian Albrechts Universität zu Kiel, Kiel

28007

Hospital Gregorio Marañón, Madrid

31073

Hôpital Purpan, Toulouse

33604

Hôpital du Haut-Levèque, Pessac

34128

Paracelsus-Elena-Klinik, Kassel

35033

Klinik für Neurologie, Marburg

35745

Boehringer Ingelheim Investigational Site, Herborn

41071

Hospital Clínico Universitario Vírgen de la Macarena, Seville

44791

St. Josef-Hospital, Bochum

44800

Hôpital Guillaume et René Laennec, Saint-Herblain

59037

Hôpital Roger Salengro, Lille

63003

Hôpital Gabriel Montpied, Clermont-Ferrand

65191

Deutsche Klinik für Diagnostik GmbH, Wiesbaden

69677

Hôpital Pierre Wertheimer, Bron

75013

Service de Neurologie, Paris

81377

Klinikum Großhadern der L.M.-Universität, München

86021

Centre Hospitalier Universitaire JB Miletrie, Poitiers

89075

Universitätsklinikum Ulm, Ulm

07551

Boehringer Ingelheim Investigational Site, Gera

04103

Universität Leipzig, Leipzig

5223 GV

Locatie Willem-Alexander, 's-Hertogenbosch

4818 CK

Boehringer Ingelheim Investigational Site, Breda

9728 RM

Martini ziekenhuis, Groningen

6163 BK

Maasland Ziekenhuis, Sittard

3584 CX

Boehringer Ingelheim Investigational Site, Utrecht

08035

Hospital Vall d'Hebrón, Barcelona

08036

Hospital Clinic i Provincial de BCN, Barcelona

08041

Hospital de la Sta. Creu i Sant Pau, Barcelona

B18 7QH

City Hospital, Birmingham

BB2 3L0

Neurology Department, Blackburn

G51 4TF

Neurology Department, Glasgow

L9 7LJ

Walton Centre for Neurology, Liverpool

NE4 6BE

Regional Neurosciences Centre, Newcastle upon Tyne

ST4 7LN

Neurology Research, Stoke-on-Trent

6AS 6NL

Neurology Department, Swansea

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY